EP3684320A1 - Verfahren zum befüllen einer medizinischen verpackung, befüllvorrichtung, sowie als beutel ausgebildete medizinische verpackung - Google Patents
Verfahren zum befüllen einer medizinischen verpackung, befüllvorrichtung, sowie als beutel ausgebildete medizinische verpackungInfo
- Publication number
- EP3684320A1 EP3684320A1 EP18773762.2A EP18773762A EP3684320A1 EP 3684320 A1 EP3684320 A1 EP 3684320A1 EP 18773762 A EP18773762 A EP 18773762A EP 3684320 A1 EP3684320 A1 EP 3684320A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- liquid
- filling
- nozzle
- gas
- bag
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004806 packaging method and process Methods 0.000 title claims abstract description 69
- 238000000034 method Methods 0.000 title claims abstract description 39
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 183
- 239000007788 liquid Substances 0.000 claims abstract description 164
- 239000007789 gas Substances 0.000 claims abstract description 110
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 92
- 230000001681 protective effect Effects 0.000 claims abstract description 43
- 239000011261 inert gas Substances 0.000 claims abstract description 41
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000001301 oxygen Substances 0.000 claims abstract description 36
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 36
- 239000012298 atmosphere Substances 0.000 claims description 22
- 238000009517 secondary packaging Methods 0.000 claims description 11
- 230000004888 barrier function Effects 0.000 claims description 9
- 239000012530 fluid Substances 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 7
- 239000011888 foil Substances 0.000 claims description 7
- 235000016236 parenteral nutrition Nutrition 0.000 claims description 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 6
- 229940127557 pharmaceutical product Drugs 0.000 claims description 6
- 229910052751 metal Inorganic materials 0.000 claims description 4
- 239000002184 metal Substances 0.000 claims description 4
- 238000012856 packing Methods 0.000 claims 1
- 238000005429 filling process Methods 0.000 description 9
- 238000003466 welding Methods 0.000 description 8
- 230000005499 meniscus Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 239000006096 absorbing agent Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 239000000969 carrier Substances 0.000 description 3
- 238000003032 molecular docking Methods 0.000 description 3
- 229920000098 polyolefin Polymers 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 239000013013 elastic material Substances 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 229960005420 etoposide Drugs 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- MFWNKCLOYSRHCJ-BTTYYORXSA-N granisetron Chemical compound C1=CC=C2C(C(=O)N[C@H]3C[C@H]4CCC[C@@H](C3)N4C)=NN(C)C2=C1 MFWNKCLOYSRHCJ-BTTYYORXSA-N 0.000 description 1
- 229960003727 granisetron Drugs 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229910052754 neon Inorganic materials 0.000 description 1
- GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229960000707 tobramycin Drugs 0.000 description 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1412—Containers with closing means, e.g. caps
- A61J1/1431—Permanent type, e.g. welded or glued
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1462—Containers with provisions for hanging, e.g. integral adaptations of the container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1468—Containers characterised by specific material properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
- A61J1/1481—Inlet or outlet ports with connection retaining means, e.g. thread or snap-fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/16—Holders for containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
- B65B31/02—Filling, closing, or filling and closing, containers or wrappers in chambers maintained under vacuum or superatmospheric pressure or containing a special atmosphere, e.g. of inert gas
- B65B31/024—Filling, closing, or filling and closing, containers or wrappers in chambers maintained under vacuum or superatmospheric pressure or containing a special atmosphere, e.g. of inert gas specially adapted for wrappers or bags
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D1/00—Containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material, by deep-drawing operations performed on sheet material
- B65D1/09—Ampoules
- B65D1/095—Ampoules made of flexible material
Definitions
- the invention relates to a method of filling a pouched medical package.
- the invention relates to a method for filling bags with an infusion fluid, for example a
- the invention further relates to a device for filling a medical packaging in the form of a bag and a medical packaging in the form of a bag, which is filled with an infusion liquid.
- Such a bag has at least one port.
- the port generally includes a septum, which may be with a spike or a needle
- Residual volume should, depending on what liquid is present in the bag, contain as little oxygen as possible Otherwise, an active ingredient may decompose or spoil a liquid for parenteral nutrition.
- the films used for pouched medical packaging may have a reduced barrier to oxygen, it is known in the art to place the pouch in a secondary pouch which includes an oxygen barrier.
- the invention relates to the provision of a trained as a bag medical packaging, which can be dispensed with the introduction of an oxygen absorber in the secondary packaging even with oxygen-sensitive content. Summary of the invention
- the object of the invention is achieved by a method for
- the invention generally relates firstly to a method for filling a medical bag
- the invention relates to a method in which bags are filled with an active ingredient-containing liquid or a liquid for parenteral nutrition.
- the present invention is described by a method for filling a, preferably designed as a bag, medical packaging, the packaging over a
- Access is filled with a liquid and the access is provided when filling in a protective gas atmosphere, characterized in that the packaging is filled prior to filling with the liquid with an inert gas.
- the above-mentioned method of filling can also be described as a method for producing a pharmaceutical product, in which a, preferably designed as a bag, medical packaging is filled, the package is filled with liquid via an access and the access when filling in a protective gas atmosphere is provided thereby
- the packaging is filled with an inert gas before being filled with the liquid.
- the packaging is designed in particular as a foil bag. According to one embodiment of the invention, it is a bag of two welded together
- Polyolefin films in particular polypropylene films.
- the films may be single-layered or multi-layered.
- the polyolefin-containing layers provide the inner layers that are in contact with the liquid.
- the bag comprises at least one port, via which the bag can be filled with liquid or filled.
- the port also serves to remove liquid.
- the port may have a septum for sealing in the finished state of the bag, by introducing a
- the port is a component manufactured by injection molding.
- the port can also be provided by a simple tube section.
- the port is welded between the films.
- it is a port with a tapered Einsch spaschiffchen, which is welded in a weld of the bag.
- the bag is filled with a liquid via an access, wherein the access during filling in a, preferably locally limited, protective gas atmosphere
- the protective gas is a gas which
- the inert gas is or comprises an inert gas.
- the protective gas comprises or is nitrogen.
- the bag is filled by means of a liquid nozzle.
- the access in the bag may, for example, be provided via an opening in the weld.
- access is provided by the port.
- the bag is filled with liquid via a liquid nozzle, the port, in particular a filling opening of the port, being filled with the protective gas, preferably nitrogen, during filling.
- Liquid nozzle and the filling opening of the port extends around.
- the locally limited protective gas atmosphere can be provided as a displacement flow.
- the protective gas flow is at least
- the packaging in particular the bag, is filled with an inert gas before being filled with liquid. It is thus in addition to a fumigation of the area of
- a port to provide a protective gas atmosphere additionally introduced before filling actively an inert gas in the bag designed as medical packaging.
- the filling of the Inertgases by means of a gas nozzle to which in particular the filling opening of the access, for example, the port of the bag is docked.
- at least one opening is provided for providing the protective gas atmosphere, which extends at least in sections around the liquid nozzle and / or the gas nozzle.
- Bag with the inert gas in a surprisingly efficient way, the residual oxygen content in the remaining gas volume of the filled and sealed bag can be reduced.
- the atmosphere of the gas space of the filled and sealed bag is already provided in advance in the bag that has not yet been filled, although the actual filling of the bag with the liquid is only then carried out.
- the packaging is filled with a volume of inert gas which corresponds at least to the volume of a gas volume remaining after filling the packaging. So it will be at least or in
- a volume of inert gas preferably
- Nitrogen from 10 to 50 ml, preferably from 15 to 30 ml, filled.
- the inert gas in one embodiment is at least one gas selected from a group consisting of nitrogen, argon, helium, neon, and carbon dioxide.
- nitrogen is used as the inert gas. Because it serves, among other things, to displace the oxygen and thereby prevent oxidation of the contents as possible.
- the bag is evacuated prior to filling with the inert gas.
- the evacuation is preferably via the
- the packaging is preferably evacuated to a pressure of less than 300 mbar, preferably of less than 100 mbar, more preferably of less than 50 mbar.
- neither gas is vented nor gas introduced during the filling with the liquid from the inner volume of the bag.
- the filling opening of the bag access or the port can be tightly docked to the liquid nozzle.
- the medical packaging designed as a bag is first tested for leaks by first evacuating it and, after closing the vacuum, checking whether there is a pressure increase due to a leaking of the packaging.
- the packaging is evacuated and then filled with the inert gas.
- the package is filled using a filling head with the liquid.
- the filling head has a gas nozzle and a Fluid nozzle on.
- the packaging is first docked to the gas nozzle and after filling with inert gas, preferably nitrogen, to the
- Liquid nozzle implemented.
- the liquid nozzle and / or the gas nozzle are each sealingly connected to the filling opening of the access, e.g. port, bag.
- Liquid nozzle continuously gassed with the inert gas to provide the inert gas atmosphere.
- the access, in particular the port, of the bag when the package is shut off from the gas nozzle to the liquid nozzle is preferably closed off.
- the bag Conversion by occurring forces forming deformations of the bag, gas flows in or is pushed out.
- the bag for shutting off, preferably pressing, the bag, in particular a squeezing pliers is used.
- the bag is pressed with the squeezer by the squeezing pliers.
- Contact surface of a jaw of the closed tongs surrounds the weld-in portion of a port and extends at least until a weld of the bag.
- Embodiment of the invention is the squeezing pliers
- a jaw of the squeezing pliers substantially U-shaped and presses the film around the
- the port itself can also have an area that is squeezed off to the port before and / or after the filling process
- the packaging After being filled with the liquid, the packaging is preferably moved to a closing device in which the access is then closed.
- the access can be closed by welding, in particular an opening in the weld.
- the bag is moved to a shutter and by placing the
- the closure may in particular be a
- Bounce lock act may be a closure designed as a cap, which is already provided with a pierceable septum and in particular is closed with a break-off part.
- the closure is preferably applied fully automatically by the closing device, which has a
- Closure recording has.
- the closure is gassed before and / or during the placement process with a protective gas, for example nitrogen.
- a protective gas for example nitrogen.
- existing oxygen can be displaced thereby.
- the access or port is gassed in particular in the region of the filling opening during the placement of the closure with a protective gas, for example nitrogen. It is especially provided that the access or port is first docked to the gas nozzle. The bag is then evacuated and filled with the inert gas. Then the bag is attached to the a protective gas, for example nitrogen.
- a protective gas for example nitrogen. It is especially provided that the access or port is first docked to the gas nozzle. The bag is then evacuated and filled with the inert gas. Then the bag is attached to the
- Liquid nozzle implemented and filled. Finally, the bag is transferred to a closing device or closure receptacle, where the access is closed, in particular the closure is placed. It should be noted that between the filling and closing of the bag
- Liquid nozzle as well as during the process from the gas nozzle to the liquid nozzle, as well as during the
- a protective gas preferably nitrogen.
- the gassing takes place in particular by generating a laminar protective gas flow around the access or around the port, in particular the filling opening of the access or port.
- the bag is shut off during the process for closing, in particular the closure receptacle, preferably closed.
- the bag is shut off from the liquid nozzle before undocking and then moved to the closing device, where the access is closed.
- the packaging is filled hanging.
- the bag is preferably oriented such that the filling opening, in particular of the port, is directed upwards during filling with the inert gas and during filling with the liquid.
- existing liquid for example, an existing drop
- the liquid for example the drop, is preferably withdrawn in such a way that after retraction an edge of the liquid nozzle is still in contact with the liquid. It does not withdraw so much liquid that one
- Section of the liquid nozzle or the fluid line leading to the liquid line is empty. The liquid is only withdrawn so far that no more drops
- Packaging is filled via a port with a liquid and the access is provided when filling in a protective gas atmosphere.
- the method is characterized in that the packaging is filled with an inert gas before being filled with the liquid.
- the inert gas then provides the gas space of the filled and sealed packaging. Possible embodiments of the method can be found in the previously described embodiments of the method.
- the invention furthermore relates to a device for filling a medical bag
- the device is designed in particular for use of the method described above.
- the apparatus comprises a filling head with a gas nozzle for filling an inert gas into the packaging and with a liquid nozzle for filling the packaging.
- An opening for providing a protective gas atmosphere extends at least in sections around the liquid nozzle and / or the gas nozzle.
- the filling head is preferably formed in one piece.
- Gas nozzle and the liquid nozzle are preferably spaced apart.
- a protective gas preferably
- Openings at least in sections on a circle around the gas nozzle and / or the liquid nozzle are achieved via the openings in the region of the gas nozzle and / or the liquid nozzle, so that the outlet opening of the gas nozzle and / or the liquid nozzle is completely located in a protective gas atmosphere.
- the gas nozzle and / or the liquid nozzle is located in a depression, wherein the gas nozzle and / or the
- Liquid nozzle has or have a spaced from an edge of the drain opening.
- a bell is formed, within which the liquid nozzle and / or the gas nozzle are arranged.
- the bell formed by the sink is preferably during the entire filling process with the protective gas, preferably
- the filling head further comprises a channel from which a protective gas, preferably nitrogen, exits, via which an outlet opening of the liquid nozzle is blown with the protective gas.
- a protective gas preferably nitrogen
- the invention relates to the use of the device described above for filling a bagged medical packaging.
- the invention furthermore relates to a pharmaceutical product comprising a medical packaging designed as a bag, which can be produced or manufactured in particular by the method described above and / or in particular using the device described above.
- the pouched medical package is filled with a liquid, in particular with an active ingredient-containing liquid or a solution for parenteral nutrition.
- the liquid is an intravenous medicinal liquid to be administered.
- the liquid is a preferably high-level, oxygen-sensitive, intravenously administered medicinal liquid.
- the active ingredient is at least one active ingredient selected from a group consisting of paracetamol, cyanocobalamin, dexamethasone, etoposide, gentamicin,
- the active ingredient may be dissolved and / or dispersed in the liquid.
- the internal volume of the medical package or the bag has a gas volume.
- the oxygen content in the gas volume of the package, at least immediately after filling is less than 1% by volume, preferably less than 0.5% by volume.
- the gas volume present in the bag is 10 to 50 ml, preferably 15 to 30 ml.
- the volume can be determined simply by taking a gas with a needle syringe from the filled and closed bag.
- the invention is also characterized by a relatively low nitrogen consumption.
- nitrogen atmosphere are under 20 liters per minute, preferably less than 10 liters per minute, for example, about 8 Liters per minute, each filling station consumes nitrogen.
- the packaging is arranged in a secondary packaging which comprises an oxygen barrier, preferably a metal foil.
- the secondary packaging has at least one metal layer, which as
- Oxygen barrier acts. This may be, for example, an aluminum foil.
- the secondary packaging is provided by a deep-drawn film, preferably an aluminum foil, into which the packaging is inserted and which is closed by a, preferably transparent, film which has an oxygen barrier.
- the oxygen barrier in the cover sheet may be provided, for example, by a silica and / or alumina layer.
- the secondary packaging can also be evacuated and / or with a protective gas, e.g. Nitrogen, be filled.
- a protective gas e.g. Nitrogen
- the medical packaging designed as a bag ie the primary bag
- An oxygen absorber such as pickled iron filings, is preferably not in the package.
- Fig. 1 is a schematic representation of a system for filling a trained as a bag medical
- FIG. 2 shows a trained as a bag medical
- Packaging which is inserted in a secondary packaging.
- Fig. 3 shows in a side view parts of the system for filling, wherein in this view, the closure receptacle for placing the closure is shown.
- Fig. 4 is another view of the filling apparatus, in which view the components around the closure and the port are hidden.
- Fig. 5 is a perspective view of the filling apparatus showing the squeezing pliers for closing the port.
- 5a and 5b are perspective detail views of the filling device in which the opposite jaws of the squeezing pliers are shown in the closed state with a bag (FIG. 5a) and in the opened state without a bag (FIG. 5b).
- Fig. 6 is a detail view of a port without an attached closure.
- Fig. 7 is a plan view of the underside of the filling head, showing the liquid nozzle and the nitrogen nozzle.
- Fig. 8 shows a sectional view of the filling head.
- 9 shows in a flow chart the method steps of an embodiment of the invention.
- FIG. 1 shows a schematic diagram of the components of a device 1 for filling a medical package 20 in the form of a bag.
- the device 1 comprises a filling head 2 designed as a block in this embodiment, which comprises a gas nozzle 3 and a liquid nozzle 4.
- the gas nozzle 3 provides the inert gas for pre-filling the bag.
- nitrogen is used as the inert gas.
- the gas nozzle 3 will be briefly referred to as nitrogen nozzle 3 in the following description
- the liquid nozzle 4 and the nitrogen nozzle 3 are arranged side by side and spaced from each other.
- the access 20 to the bag is provided through the fill port 51 of the port 22.
- the nitrogen nozzle 3, to which the medical package 20 is docked with a filling opening 51 of the port 22, serves both to fill the bag-formed medical package 20 with nitrogen and the
- Vacuum line 17 connected.
- a docked bag 20 is evacuated via the valve 19 and the valve 16 designed as a switching valve.
- a filling opening 51 of the bag 20 (see FIG. 6) is sealingly connected to the nitrogen nozzle 3 docked, for example, pressed.
- the nitrogen nozzle 3 may be made of an elastic material, for example. Alternatively or additionally, the nitrogen nozzle 3 may comprise a seal.
- the vacuum used for evacuation (before filling) is also referred to below as "deep vacuum.” This is a vacuum, in which preferably a pressure of less than 100 mbar is applied to the filling opening 51.
- a container 18 which serves as a buffer volume. Due to the buffer volume, the pressure drop occurring at the nitrogen nozzle 3 when opening the valves 16 and 19 is reduced.
- the nitrogen nozzle 3 is connected to a further vacuum line 12.
- Switching valve 16 and the valves 14 and 15 can also be applied via the vacuum line 12 vacuum on the nitrogen nozzle 3.
- a container 13 is arranged, which is provided with a pressure sensor (not shown), which measures the pressure inside the container 13.
- the container 13 is evacuated via the valve 14 with the valve 15 still closed in a first step.
- the valve 14 is closed.
- the valves 15 and 16 are opened.
- the valve 19 is or remains closed. In the event of a leak is in the container 13 a
- the pressure in this integrity test need not be as deep as evacuating the bag 20 prior to its filling in a subsequent step. If the bag 20 has passed the leak test, the valve 15 is closed and the valve 19 is opened. Via the vacuum line 17 then there is a higher negative pressure to the nitrogen nozzle. The at the nitrogen nozzle 3
- the bag 20 is filled with nitrogen as an inert gas.
- nitrogen as an inert gas.
- at least the valve 16 is closed.
- a defined volume of nitrogen is introduced into the bag 20 via the nitrogen nozzle 3.
- the supply line 8 leads via a container 10.
- valve 49 is opened, wherein the valve 11 is still closed.
- the container 10 is now filled with nitrogen, wherein the pressure setting in the container 10 corresponds to the pressure applied via the feed line 8.
- Nitrogen can now relax and it escapes through the nozzle 3 while nitrogen in a docked bag 20 until a pressure equalization has taken place.
- About the volume of the container 10 and the pressure in the container 10 and the pressure in the supply line 8 is determined which volume nitrogen flows into the bag 20.
- a pressure for the nitrogen supply of the gassing of 0.5 bar to 4.0 bar is provided in the container 10.
- the container 10 is dimensioned and / or the pressure in the container 10 is so selected that the nitrogen olumen, which flows into the bag 20 including the volume of the port 22, the desired remaining gas volume of the bag 20 after its filling with liquid corresponds.
- the access 22 to the bag 20, here the filling opening 51 of the port 22, is shut off, preferably closed (see the following FIGS. 5 to 5b and 9).
- the liquid nozzle 4 is connected via the supply line 7 with a reservoir (not shown), via which a docked to the liquid nozzle 4 medical
- Packaging 20 is filled with liquid.
- the medical package 20 is thereby docked with a filling opening 51 on the liquid nozzle 4.
- a filling opening 51 on the liquid nozzle 4.
- the liquid nozzle 4 is applied by pressing sealing to the filling opening.
- Fluid nozzle may have a seal or consist of a sealing elastic material.
- the device 1 for filling comprises at least one valve 5, 6. In this
- valves designed as switching valves 5, 6 are arranged one behind the other.
- a valve 6 is used for fine dosing and is designed such that it can change the volume in the inlet, whereby a small amount of
- Liquid can be withdrawn. This is after undocking the medical packaging 20 of the
- Liquid nozzle 4 prevents dripping and dripping.
- the bag 20 is temporarily closed again (see also FIGS. 5 to 5b and 9) and moved to a closing device, not shown here, here in the form of a closure receptacle 29.
- the port 22 is on the closure receptacle 29 with a
- Fig. 2 shows a trained as a bag 20 medical packaging 20.
- the bag 20 consists of a
- the bag 20 comprises an inner volume 21 which is preferably between 50 and 1000 ml, more preferably between 80 and 150 ml.
- the bag 20 comprises a hanger 25 and a welded in the transverse weld 54 port 22, which is closed with a bounced closure 23, which in this embodiment has a break-off cap 24.
- the bag 20 is inserted in a secondary bag 48, which serves as secondary packaging.
- the bag in his
- Secondary bag is subsequently sterilized, preferably thermally.
- the secondary bag 48 may be used to remove the bag 20, e.g. be torn up.
- the secondary bag 48 is preferably made of a film having a
- the secondary bag 48 may be filled with nitrogen
- FIG. 5a and 5b show a side view of parts of the device 1 for filling a bag 20.
- the closing device in the form of the closure receptacle 29 is shown. This can, in this embodiment via a pneumatic suction, a shutter 23 record, which is manufacturedprellt on the port 22 of a bag 20.
- Other connections, in particular the connection for the supply of liquid for filling the bag 20 are not visible in this view.
- the device comprises a movable support 28, in which there is a channel 30, via which the closure 23 and the port 22 of the bag 20 are gassed with nitrogen.
- the channel 30 is directed obliquely upward, so that the exiting nitrogen flow that of the
- the carrier 28 for the channel 30 can be moved upwards in order to be able to escape when feeding a bag 20 to be filled, in particular in order to be able to avoid a carrier 44 which holds the bag 20 (see FIGS. 4 and 5) ).
- a fill head 2 In the image plane behind the closure receptacle 29 is a fill head 2, which can not be seen in this illustration for filling the bag 20 with liquid and for filling with nitrogen.
- Fig. 4 is another view of the Appendix 1 for filling formed as a bag 20 medical packaging 20.
- the carrier 44 is shown, which serves as a gripping member for the bag 20 and this the
- Nitrogen nozzle 3 the liquid nozzle 4 and the
- the bag 20 is grasped at the port 22 and moved from the carrier 44 to the nitrogen nozzle 3 and to the liquid nozzle 4 and to the closure receptacle 29. Via the channel 30, the closure 23 is gassed in the region of the filling opening 51 of the port 22.
- a support 31 on which a jaw 32b of the squeezing pliers 32 (see also FIG. 5, as well as FIGS. 5a and 5b) is movably arranged.
- the squeezer 32 can be opened and closed to push the bag 20 around the port 22. Otherwise, the carrier 31 is moved together with the carrier 44.
- Squeezing pliers 32 can be seen.
- the squeezing pliers 32 are designed in such a way that the film material of the bag 20 is compressed around the welded-in port 22 and the bag 20 can thus be pressed shut.
- the bag 20 is so shut off or temporarily closed by closing the squeezing pliers 32 around the port 22 around. With the squeezing pliers 32, the bag 20 is shut off or closed when it is displaced to carry out the various process steps during filling.
- the carrier 28 for the channel 30 for gassing the closure 23 with nitrogen can, as described above, be moved in height in order to avoid the carrier 44. By shutting down the carrier 28 can via the channel 30th
- Nitrogen are blown into the closure 23.
- 5a and 5b show perspective cutaway detail views of the device 1 for filling, in which the area of the squeezing pliers 32 is shown.
- FIG. 5 a shows how the closed pinching tongs 32 presses a bag 20.
- the squeezer 32 includes the
- Fig. 5b is a perspective cutaway view of the opened squeeze pliers 32 (without bag 20).
- the jaw 32b comprises a recess 52 open at the top, in which, when the squeeze pliers are closed, there is a weld-in section of a port 22, in particular a weld-in boat 34.
- the recess 52 is formed substantially U-shaped.
- the opposing jaw 32a is a type of open hollow body or case.
- the jaw 32a is formed by the base plate 32a-l, the two lateral side walls 32a-2 and 32a-3 and the lower side wall 32a-4 (The two side walls 32a-3 and 32a-4 are not visible in the perspective shown.)
- the welding jaw 32a Towards the top in the direction of the port 22 and laterally in the direction of the welding jaw 32b, the welding jaw 32a is designed to be open.
- the welding jaw 32a is substantially U-shaped.
- the U-shape or U-shaped portion of the welding jaw 32a is formed by the side walls 32a-2, 32a-3, 32a-4 of the jaw 32a.
- the position 53 of the contact surface of the jaw 32a on the bag is shown in FIG.
- the end faces of the side walls 32a-2, 32a-3, 32a-4 of the jaw 32a come to rest at the position 53.
- the contact surface 53 is also U-shaped, wherein the base is disposed below the welding boat 34 of the port 22.
- the legs of the abutment surface 53 extend laterally along the Einsch doschiffchens 34 and extend at least up to the height of a transverse weld 54 of the bag 20.
- the bag 22 can be pressed with the squeezer 32 to the weld-in portion of the port 22 around.
- the port 22 comprises a tapered weld-in boat 34, which serves as a weld-in section, and a filling opening 51, below which a collar 33 is located. On the collar 33, the closure 23 can be thoroughlyprellt.
- the bag 20 is filled with liquid via the filling opening 51.
- the filling opening 51 also serves to form a port 22 provided with a septum when the
- the filling opening 51 of the port 22 can be sealingly docked both to the nitrogen nozzle 3 and to the liquid nozzle 4.
- FIG. 7 and FIG. 8 show different views of FIG.
- the filling head 2 is seated in the mounted state behind the closure receptacle 29 shown in Fig. 3.
- the filling head 2 comprises a connector for attachment to the system 1.
- the filling head 2 comprises a product connection and a gas connection. Via the product connection, which is connected to the liquid nozzle 4, liquid for filling the bag 20 is supplied.
- the gas connection which is connected to the nitrogen nozzle 3, the bag 20 can be both evacuated and filled with nitrogen.
- a fine metering can be made.
- a Volume change can be effected in the liquid inlet, whereby a drop of liquid can be withdrawn.
- Fig. 7 is a plan view of the bottom of the
- the filling head 2 comprises a nitrogen nozzle 3 and a liquid nozzle 4.
- the liquid nozzle 4 has a larger diameter than the nitrogen nozzle 3.
- the diameter of the liquid nozzle 4 is between 4.5 and 6.5 mm.
- the diameter of the nitrogen nozzle 3 is
- the nitrogen nozzle 3 When installed, the nitrogen nozzle 3 is located behind the closure receptacle 29 shown in FIG. 3. The liquid nozzle 4 then follows. The nitrogen nozzle 3 is arranged between the liquid nozzle 4 and the closure receptacle 29.
- Both the nitrogen nozzle 3 and the liquid nozzle 4 annular openings 38 extend from which nitrogen exits and with which a laminar flow in the direction of flow of the product, ie the liquid flow during filling, is generated.
- the openings 38 are located in a depression 39, the edge 40 of which extends along the underside of the filling head 2. Laterally adjacent to the nitrogen nozzle 3, the depression 39 is open to the side and in the assembled state directly adjoins the closure receptacle 29. It is so through the sink 39 a reaching to the closure receptacle 29 channel 42nd
- FIG. 8 is a sectional view taken along that of FIG. 7.
- the lower end of the filling head 2 is formed as an insert 41 made of stainless steel, which connected to the rest of the filling head 2, in particular glued and / or screwed, and optionally sealed with sealing rings.
- This insert 41 includes the
- the edge 45 of the liquid nozzle 4 as well as the edge 47 of the nitrogen nozzle 3 are spaced from the edge 40 of the depression 39. Thus are the outlet openings of
- Fluid nozzle 4 and nitrogen nozzle 3 within a downwardly open channel 42, which in the operating state by a
- laminar nitrogen flow is purged with nitrogen.
- a meniscus 50 is shown, which forms the liquid when the bag 20 is undocked from the liquid nozzle 4.
- Oxygen is drawn into the area of the liquid nozzle 4.
- FIG. 9 shows in a flow chart the method steps according to an embodiment of the invention.
- the bag 20 is received by means of the carrier 44 of the device 1 for filling and with the
- Bag 20 created.
- a pressure sensor in the container 13 is used to check whether the bag 20 is tight by comparing the resulting pressure drop with a predetermined reference range. If the bag 20 is tight, then a vacuum is applied via the vacuum line 17 and an opening of the valve 19. After applying the low vacuum, the valve 19 is closed.
- the bag 20 is filled with the inert gas, in this case nitrogen, by filling a defined volume of nitrogen into the bag 20 by actuating the valves 11 and 49 via the container 10.
- the filled volume essentially corresponds to the desired gas volume of the bag 20.
- the bag 20 is shut off, here pressed closed by the squeezer 32 is closed.
- the bag 20, now filled with inert gas, is then transferred from the nitrogen nozzle 3 to the filling nozzle, that is to the liquid nozzle 4.
- By closing with the squeezer 32 is prevented during the reaction that enters the bag 20 gas or exits.
- Liquid in the liquid nozzle 4 is reset, so that nothing drips out of the liquid nozzle 4, when the bag 20 is moved in the connection to the closure 23, where the port 22 is closed with the closure 23.
- Inertgas filled bag 20 also shut off, here pressed with the squeezer 32.
- the squeezer 32 is opened and the now completed filled and sealed by the closure 23 bag 20 can be ejected and removed.
- the head volume ie the area of the liquid nozzle 4, the nitrogen nozzle 3 and the filling opening 51 of the port 22 is continuously with
- the closure 23 is also purged with nitrogen, wherein a carrier 28, which includes the channel 30 provided for this purpose, is driven upwards during the feeding of the bag 20 in order to be able to escape.
- the invention has succeeded in reducing the residual oxygen content in the remaining gas volume of a bag 20 to less than 1% by volume.
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Hematology (AREA)
- Ceramic Engineering (AREA)
- Dispersion Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Vacuum Packaging (AREA)
- Basic Packing Technique (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17192684 | 2017-09-22 | ||
PCT/EP2018/075647 WO2019057918A1 (de) | 2017-09-22 | 2018-09-21 | Verfahren zum befüllen einer medizinischen verpackung, befüllvorrichtung, sowie als beutel ausgebildete medizinische verpackung |
Publications (3)
Publication Number | Publication Date |
---|---|
EP3684320A1 true EP3684320A1 (de) | 2020-07-29 |
EP3684320B1 EP3684320B1 (de) | 2023-06-07 |
EP3684320C0 EP3684320C0 (de) | 2023-06-07 |
Family
ID=59955458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP18773762.2A Active EP3684320B1 (de) | 2017-09-22 | 2018-09-21 | Verfahren zum befüllen einer medizinischen verpackung, befüllvorrichtung, sowie als beutel ausgebildete medizinische verpackung |
Country Status (5)
Country | Link |
---|---|
US (1) | US11548665B2 (de) |
EP (1) | EP3684320B1 (de) |
KR (1) | KR102687393B1 (de) |
CN (1) | CN111107822B (de) |
WO (1) | WO2019057918A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201600079175A1 (it) * | 2016-07-28 | 2018-01-28 | Fillshape Srl | Dispositivo e procedimento di verifica buste per linee di riempimento. |
KR102687393B1 (ko) * | 2017-09-22 | 2024-07-22 | 프레제니우스 카비 도이치란트 게엠베하 | 의료 포장물을 충전하는 방법, 충전 디바이스 및 파우치로서 형성된 의료 포장물 |
CN111824494A (zh) * | 2020-06-18 | 2020-10-27 | 苏州微敏检测技术服务有限公司 | 一种防吸附药物包装惰性气体保护生产系统 |
CN112456427A (zh) * | 2020-09-30 | 2021-03-09 | 上海上药第一生化药业有限公司 | 一种灌装充氮系统 |
PL4051251T3 (pl) | 2020-10-21 | 2024-04-08 | Sintetica S.A. | Stabilne, wolne od antyoksydantów roztwory noradrenaliny do wstrzykiwania |
EP4339111A1 (de) * | 2022-09-13 | 2024-03-20 | Harro Höfliger Verpackungsmaschinen GmbH | Vorrichtung und verfahren zum befüllen von beuteln |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3977445A (en) | 1973-05-02 | 1976-08-31 | Nobel Scientific Industries, Inc. | Asceptic filling apparatus and method |
JPH01279018A (ja) | 1988-04-27 | 1989-11-09 | Toyo Seikan Kaisha Ltd | 液体内容物の充填におけるヘッドスペースのガス置換方法 |
US4973327A (en) * | 1989-11-01 | 1990-11-27 | Cryopharm | Blood bag for lyophilization |
EP1241110A1 (de) | 2001-03-16 | 2002-09-18 | Pfizer Products Inc. | Ausgabeeinheit für sauerstoff-empfindlichen Medikamenten |
JP4062998B2 (ja) | 2002-07-11 | 2008-03-19 | 東洋製罐株式会社 | ガス置換方法及び装置 |
JP4466812B2 (ja) | 2003-03-03 | 2010-05-26 | 東洋製罐株式会社 | 不活性ガス置換方法とその装置 |
JP2004267384A (ja) * | 2003-03-07 | 2004-09-30 | Niccon Kohsan Co Ltd | 医療用容器の製造方法および医療用容器 |
JP4828111B2 (ja) | 2004-10-21 | 2011-11-30 | 株式会社大塚製薬工場 | 総合輸液製剤 |
SE0600764L (sv) * | 2006-04-03 | 2007-10-04 | Ecolean Res & Dev As | Anordning och metod för fyllning av en förpackning |
JP4905683B2 (ja) * | 2007-01-22 | 2012-03-28 | 東洋製罐株式会社 | スパウト付きパウチへの液状内容物充填密封方法及びその装置 |
US7776022B2 (en) * | 2007-03-19 | 2010-08-17 | Hemcon Medical Technologies | Apparatus and methods for making, storing, and administering freeze-dried materials such as freeze-dried plasma |
CN101461756B (zh) * | 2007-12-17 | 2012-07-25 | 丽珠集团利民制药厂 | 药液软包装及其包装方法 |
DK2319477T3 (da) * | 2009-11-06 | 2012-04-23 | Hoffmann La Roche | Indretning til fyldning af en fleksibel forrådsbeholder i et undertryk-kammer |
US20110207824A1 (en) | 2010-02-25 | 2011-08-25 | Moly Pharma | Formulation of an injectable paracetamol solution, method for preparing and packaging such a solution and device for packaging such a solution |
JP5739150B2 (ja) * | 2010-12-10 | 2015-06-24 | テルモ株式会社 | 医療用バッグの製造方法および医療用バッグ |
US9505504B2 (en) | 2011-02-18 | 2016-11-29 | Pouch Pac Innovations, Llc | Apparatus for the two stage filling of flexible pouches |
CN102230567B (zh) | 2011-04-28 | 2013-03-27 | 长沙汇一制药机械有限公司 | 一种软袋大输液保护气体的充装方法 |
EP2631195B1 (de) * | 2012-02-23 | 2015-04-08 | Cryovac, Inc. | Beutel und Herstellungsverfahren dafür |
JP6017295B2 (ja) | 2012-12-13 | 2016-10-26 | 東洋自動機株式会社 | 袋詰め包装における液体充填方法及び装置 |
FR3003245B1 (fr) | 2013-03-13 | 2015-03-20 | Sartorius Stedim Biotech | Reception, vidage et transfert sous pression d'une grande quantite de fluide biopharmaceutique en vue d'un traitement ulterieur. |
FR3003550B1 (fr) * | 2013-03-22 | 2016-05-06 | Sartorius Stedim North America Inc | Installation et procede pour la preparation d'un conteneur charge avec un fluide biopharmaceutique. |
KR102097341B1 (ko) * | 2013-10-24 | 2020-04-06 | 다이니폰 인사츠 가부시키가이샤 | 약액 수납 용기 및 그 드라이 에어 치환 방법 |
CN105745153B (zh) | 2013-10-28 | 2017-10-24 | 株式会社大塚制药工场 | 不活泼气体填充用喷嘴、不活泼气体填充装置和装有输液用液体的容器的制造方法 |
FR3017122B1 (fr) * | 2014-02-06 | 2016-02-26 | Sartorius Stedim Fmt Sas | Procede de chargement d'une poche souple 3d a emplir, un systeme de chargement et stockage de cette poche souple et dispositif de support associe. |
EP3034062B1 (de) * | 2014-12-19 | 2017-03-22 | Fresenius Kabi Deutschland GmbH | Konnektorsystem mit mindestens zwei Entnahmeports |
JP6685644B2 (ja) * | 2014-12-25 | 2020-04-22 | エイワイファーマ株式会社 | 輸液容器及びその製造方法 |
KR102687393B1 (ko) * | 2017-09-22 | 2024-07-22 | 프레제니우스 카비 도이치란트 게엠베하 | 의료 포장물을 충전하는 방법, 충전 디바이스 및 파우치로서 형성된 의료 포장물 |
US10974856B2 (en) * | 2018-10-12 | 2021-04-13 | Campbell Wrapper Corporation | Apparatus for flushing packages with gas |
-
2018
- 2018-09-21 KR KR1020207001290A patent/KR102687393B1/ko active IP Right Grant
- 2018-09-21 US US16/646,837 patent/US11548665B2/en active Active
- 2018-09-21 WO PCT/EP2018/075647 patent/WO2019057918A1/de unknown
- 2018-09-21 EP EP18773762.2A patent/EP3684320B1/de active Active
- 2018-09-21 CN CN201880061626.XA patent/CN111107822B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN111107822A (zh) | 2020-05-05 |
US11548665B2 (en) | 2023-01-10 |
BR112020000069A2 (pt) | 2020-07-07 |
EP3684320B1 (de) | 2023-06-07 |
US20200270003A1 (en) | 2020-08-27 |
CN111107822B (zh) | 2023-10-24 |
KR20200050942A (ko) | 2020-05-12 |
WO2019057918A1 (de) | 2019-03-28 |
EP3684320C0 (de) | 2023-06-07 |
KR102687393B1 (ko) | 2024-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3684320B1 (de) | Verfahren zum befüllen einer medizinischen verpackung, befüllvorrichtung, sowie als beutel ausgebildete medizinische verpackung | |
DE68905749T2 (de) | Aseptische fuellvorrichtung. | |
DE69804649T2 (de) | Vorrichtung zum konditionieren in einer kontrollierten atmosphäre von produkten in mit einer folie versiegelten behältern | |
DE3809852A1 (de) | Verfahren zum aseptischen bzw. sterilen abfuellen von fluessigem fuellgut in behaelter sowie vorrichtung zum durchfuehren dieses verfahrens | |
EP0212201A1 (de) | Vorrichtung und Verfahren zur luftfreien Befüllung von Behältnissen, insbesondere von flexiblen Beuteln | |
DE102010006005A1 (de) | Dosiervorrichtung und Dosierverfahren für Flüssigkeiten | |
DE69103609T2 (de) | Verfahren zum Vakuumverpacken von flüssigen oder pastösen Produkten in Spender, Vorrichtung dafür und so erhaltene Spender. | |
DE102008006410A1 (de) | Vorrichtung und Verfahren zum Füllen von offenen Säcken mit pastösen Produkten | |
WO2018028821A2 (de) | Verfahren und behälter zum transport und zur übergabe von sterilem schüttfähigem gut in einen isolator | |
DE2030532A1 (de) | Vorrichtung und Verfahren zum Spulen mit Gas bei einer Verpackungsmaschine | |
DE102007015078A1 (de) | Vorrichtung zum Minimieren des Sauerstoffgehaltes | |
WO2012080190A1 (de) | Verfahren zur befüllung einer kavität, insbesondere eines blisters einer blisterverpackung, mit einer flüssigkeit sowie halbzeug zur verwendung in einem solchen verfahren | |
EP2419341B1 (de) | Vorrichtung und verfahren zum ausrichten und öffnen von verpackungen | |
DE102008053131A1 (de) | Verfahren und Anordnung zum Sterilisieren, insbesondere zum Sterilisieren eines Adsorbers | |
EP3049332B1 (de) | Anlage zum aspetischen befüllen eines behältnisses | |
DE3142946A1 (de) | "verfahren zur verpackung von produkten in heissverschweissbaren behaeltern" | |
DE10346842B4 (de) | Vorrichtung zum Füllen und Verschließen von rohrförmigen Behältern, insbesondere in der pharmazeutischen Industrie | |
DE102008014489A1 (de) | Behandlungseinrichtung und Verfahren zum Behandeln eines mit einem Schüttgut gefüllten offenen Sacks | |
EP4001131A1 (de) | Verpackungsvorrichtung | |
EP3838839A1 (de) | Vorrichtung und verfahren zum befüllen eines behälters mit einem füllprodukt | |
EP4054972A1 (de) | VERFAHREN ZUM BEFÜLLEN UND VERSCHLIEßEN VON BEHÄLTERN | |
DE2848505A1 (de) | Vorrichtung zum abfuellen von hochvoluminoesen pulverfoermigen stoffen in staubdichte behaelter | |
DE102015016749A1 (de) | Anlage zum herstellen eines medizinischen beutels sowie verfahren zum betreiben einer derartigen anlage | |
EP3717397B1 (de) | Verschliessvorrichtung zum begasen und verschliessen von behältern, die eine einfüllöffnung aufweisen | |
DE102004007827A1 (de) | Vorrichtung zum Verschweißen eines Folienschlauches |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20200416 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40031757 Country of ref document: HK |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20221208 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: AT Ref legal event code: REF Ref document number: 1572692 Country of ref document: AT Kind code of ref document: T Effective date: 20230615 Ref country code: DE Ref legal event code: R096 Ref document number: 502018012397 Country of ref document: DE |
|
U01 | Request for unitary effect filed |
Effective date: 20230622 |
|
U07 | Unitary effect registered |
Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI Effective date: 20230628 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG9D |
|
REG | Reference to a national code |
Ref country code: NO Ref legal event code: T2 Effective date: 20230607 |
|
U20 | Renewal fee paid [unitary effect] |
Year of fee payment: 6 Effective date: 20230918 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NO Payment date: 20230808 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230908 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231007 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20231007 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R026 Ref document number: 502018012397 Country of ref document: DE |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PLAX | Notice of opposition and request to file observation + time limit sent |
Free format text: ORIGINAL CODE: EPIDOSNOBS2 |
|
26 | Opposition filed |
Opponent name: B. BRAUN MELSUNGEN AG Effective date: 20240307 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20230607 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230921 |
|
PLBB | Reply of patent proprietor to notice(s) of opposition received |
Free format text: ORIGINAL CODE: EPIDOSNOBS3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230921 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20230930 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240927 Year of fee payment: 7 |